Danazol-induced Stevens–Johnson syndrome in a patient with systemic lupus erythematosus

W Koh; Y Tay; Koh; Mja Koh; Wei Liang Koh; P Letchumanan; J Thumboo; J Avina-Zubieta; G Galindo-Rodriguez; I Robledo; M Ziemer; S Kardaun; Y Liss; M Mockenhaupt; H Lee; H Tey; S Pang; T Thirumoorthy

doi:10.1016/j.jaad.2012.12.741

Danazol-induced Stevens–Johnson syndrome in a patient with systemic lupus erythematosus

W Koh, Y Tay, Koh, Mja Koh, Wei Liang Koh, P Letchumanan, J Thumboo, J Avina-Zubieta, G Galindo-Rodriguez, I Robledo, M Ziemer, S Kardaun, Y Liss, M Mockenhaupt, H Lee, H Tey, S Pang, T Thirumoorthy

In: Journal of the American Academy of Dermatology · 2013 · vol. 68(4) , pp. AB179 · doi:10.1016/j.jaad.2012.12.741 · W4245552298

article OA: bronze CC0

🔓 Open OA copy View on OpenAlex View at publisher

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Long-term effectiveness of danazol corticosteroids and cytotoxic drugs in the treatment of hematologic manifestations of systemic lupus erythematosus 2003

References (3)

Long-term effectiveness of danazol corticosteroids and cytotoxic drugs in the treatment of hematologic manifestations of systemic lupus erythematosus via openalex
doi:10.1177/0961203310385162 via openalex
doi:10.1111/j.1365-2133.2011.10705.x via openalex

Source provenance

openalex: last seen: 2026-05-11T05:35:07.686538+00:00

License: CC0 · commercial use OK

[1] Long-term effectiveness of danazol corticosteroids and cytotoxic drugs in the treatment of hematologic manifestations of systemic lupus erythematosus 2003